BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 18035584)

  • 21. Behçets disease in children.
    Pivetti-Pezzi P; Accorinti M; Abdulaziz MA; La Cava M; Torella M; Riso D
    Jpn J Ophthalmol; 1995; 39(3):309-14. PubMed ID: 8577084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Characteristics of the distribution of major histocompatibility system antigens in retinal vasculitis in patients with Behçet's disease].
    Ermakova NA
    Vestn Oftalmol; 2003; 119(1):31-3. PubMed ID: 12608042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New insights into the pathogenesis of Behçet's disease.
    Pineton de Chambrun M; Wechsler B; Geri G; Cacoub P; Saadoun D
    Autoimmun Rev; 2012 Aug; 11(10):687-98. PubMed ID: 22197900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunopathogenesis of ocular Behçet's disease.
    Park UC; Kim TW; Yu HG
    J Immunol Res; 2014; 2014():653539. PubMed ID: 25061613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Outcome of Behçet disease in ophthalmologic practice in Morocco].
    Ouazzani B; Benchekroun N; el Aouni A; Hajji Z; Chaoui Z; Berraho-Hamani A
    J Fr Ophtalmol; 1995; 18(5):373-5. PubMed ID: 7560773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Behçet's syndrome (a complex of mucocutaneous and ocular symptoms].
    Kobayashi T; Eefsen RL; Kobayashi-Sørensen C
    Ugeskr Laeger; 2008 Apr; 170(17):1440-5. PubMed ID: 18462621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenesis and therapy of Behçet's disease.
    Emmi L; Brugnolo F; Marchione T
    Ann Ital Med Int; 1997; 12(1):20-5. PubMed ID: 9284594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomic surveillance of autoimmunity in Behcet's disease with uveitis: selenium binding protein is a novel autoantigen in Behcet's disease.
    Okunuki Y; Usui Y; Takeuchi M; Kezuka T; Hattori T; Masuko K; Nakamura H; Yudoh K; Usui M; Nishioka K; Kato T
    Exp Eye Res; 2007 May; 84(5):823-31. PubMed ID: 17343851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uveitis in Behçet's disease.
    Nussenblatt RB
    Int Rev Immunol; 1997; 14(1):67-79. PubMed ID: 9203027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects.
    Tognon S; Graziani G; Marcolongo R
    Ann N Y Acad Sci; 2007 Sep; 1110():474-84. PubMed ID: 17911463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behçet's disease.
    Marshall SE
    Best Pract Res Clin Rheumatol; 2004 Jun; 18(3):291-311. PubMed ID: 15158742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Behçet's disease: from hippocrates to TNF-alpha-blockers].
    Zuber PJ; Bart AP; Leimgruber A; Spertini F
    Rev Med Suisse; 2008 Apr; 4(154):1045-8, 1050-4. PubMed ID: 18557534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical features of Behçet's disease in children.
    Borlu M; Ukşal U; Ferahbaş A; Evereklioglu C
    Int J Dermatol; 2006 Jun; 45(6):713-6. PubMed ID: 16796634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Retinal vasculitis in Behçet's disease].
    Ermakova NA; Alekberova ZS
    Vestn Oftalmol; 2001; 117(1):44-6. PubMed ID: 11339043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical features of late-onset Behçet's disease: report of nine cases.
    Saricaoglu H; Karadogan SK; Bayazit N; Yucel A; Dilek K; Tunali S
    Int J Dermatol; 2006 Nov; 45(11):1284-7. PubMed ID: 17076707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to deal with Behcet's disease in daily practice.
    Davatchi F; Shahram F; Chams-Davatchi C; Shams H; Nadji A; Akhlaghi M; Faezi T; Sadeghi Abdollahi B
    Int J Rheum Dis; 2010 May; 13(2):105-16. PubMed ID: 20536594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Behcet's disease].
    Bogić M; Rasković S; Sojić J; Milićević B
    Srp Arh Celok Lek; 1995; 123(9-10):261-5. PubMed ID: 17974445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behçet's disease: New insights into pathophysiology, clinical features and treatment options.
    Greco A; De Virgilio A; Ralli M; Ciofalo A; Mancini P; Attanasio G; de Vincentiis M; Lambiase A
    Autoimmun Rev; 2018 Jun; 17(6):567-575. PubMed ID: 29631062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical granulocyte colony-stimulating factor for the treatment of oral and genital ulcers of patients with Behçet's disease.
    Bacanli A; Yerebakan Dicle O; Parmaksizoglu B; Yilmaz E; Alpsoy E
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):931-5. PubMed ID: 16922940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical-immunological disorders in uveitis in patients with Behçet's syndrome].
    Teplinskaia LE; Kaliberdina AF; Zaĭtseva NS; Bulanova TD; Katsnel'son LA
    Vestn Oftalmol; 1994; 110(3):23-5. PubMed ID: 7810037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.